Agios Pharmaceuticals, Inc.
DE ˙ DB ˙ US00847X1046
23,40 € ↑0,80 (3,54%)
2026-06-04
DEL PRIS
SecurityDE:8AP / Agios Pharmaceuticals, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership47,701 shares
Latest Disclosed Value $ 1,613,725
Alps Advisors Inc reports 0.38% decrease in ownership of 8AP / Agios Pharmaceuticals, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 47,701 shares of Agios Pharmaceuticals, Inc. (DE:8AP) valued at $1,230,686 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 47,881 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of -0.38% during the quarter. The current value of the position is $1,116,203 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 47,701 -180 -0.38 1,614 23.79 0.0076
2026-02-12 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 47,881 20,327 73.77 1,303 17.81 0.0076
2025-11-05 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 27,554 -3,720 -11.89 1,106 6.35 0.0062
2025-08-11 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 31,274 -10,945 -25.92 1,040 -15.93 0.0060
2025-04-30 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 42,219 -3,892 -8.44 1,237 -18.35 0.0072
2025-02-13 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 46,111 3,105 7.22 1,515 -20.68 0.0096
2024-11-12 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 43,006 -1,286 -2.90 1,911 0.05 0.0128
2024-08-13 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 44,292 4,652 11.74 1,910 64.71 0.0131
2024-05-14 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 39,640 1,796 4.75 1,159 37.65 0.0082
2024-02-14 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 37,844 -3,255 -7.92 843 -17.21 0.0066
2023-11-14 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 41,099 243 0.59 1,017 -12.10 0.0084
2023-08-14 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 40,856 4,434 12.17 1,157 38.40 0.0101
2023-05-10 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 36,422 -823 -2.21 837 -20.00 0.0074
2023-02-14 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 37,245 7,290 24.34 1,046 23.38 0.0093
2022-11-14 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 29,955 -2,548 -7.84 847 17.48 0.0080
2022-08-15 2022-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 32,503 -23,657 -42.12 721 -55.90 0.0070
2022-08-11 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 32,503 -23,657 721 0.0069
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 56,160 -6,689 -10.64 1,635 -20.86 0.0177
2022-02-09 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 62,849 -9,405 -13.02 2,066 -38.05 0.0232
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 72,254 -8,544 -10.57 3,335 -25.11 0.0321
2021-08-11 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 80,798 -44,504 -35.52 4,453 -31.19 0.0394
2021-05-07 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 125,302 385 0.31 6,471 19.55 0.0632
2021-02-03 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 124,917 124,917 5,413 0.0610
2020-02-07 2019-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -117,158 -100.00 0 -100.00
2019-11-04 2019-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 117,158 -5,286 -4.32 3,796 -37.85 0.0296
2019-08-07 2019-06-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 122,444 -11,976 -8.91 6,108 -32.62 0.0452
2019-05-01 2019-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 134,420 -28 -0.02 9,065 46.23 0.0642
2019-02-04 2018-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 134,448 31,824 31.01 6,199 -21.67 0.0481
2018-10-25 2018-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 102,624 19,327 23.20 7,914 12.80 0.0519
2018-08-02 2018-06-30 13F/A-2 Agios Pharmaceuticals COMMON STOCK 00847X104 83,297 8,580 11.48 7,016 14.83 0.0458
2018-07-31 2018-06-30 13F/A-1 Agios Pharmaceuticals COMMON STOCK 00847X104 53,416 -29,881 3,054 0.0195
2018-07-25 2018-06-30 13F Agios Pharmaceuticals COMMON STOCK 00847X104 53,416 -21,301 3,054
2018-05-01 2018-03-31 13F Agios Pharmaceuticals COMMON STOCK 00847X104 74,717 21,301 39.88 6,110 100.07 0.0486
2018-02-20 2017-12-31 13F/A-1 Agios Pharmaceuticals COMMON STOCK 00847X104 53,416 5,943 12.52 3,054 -3.63 0.0211
2018-02-05 2017-12-31 13F Agios Pharmaceuticals COMMON STOCK 00847X104 53,416 5,943 3,054
2017-11-03 2017-09-30 13F Agios Pharmaceuticals COMMON STOCK 00847X104 47,473 3,962 9.11 3,169 41.54 0.0225
2017-08-03 2017-06-30 13F Agios Pharmaceuticals COMMON STOCK 00847X104 43,511 7,176 19.75 2,239 5.51 0.0156
2017-05-12 2017-03-31 13F Agios Pharmaceuticals COMMON STOCK 00847X104 36,335 -4,042 -10.01 2,122 25.93 0.0146
2017-01-24 2016-12-31 13F Agios Pharmaceuticals Common Stock 00847X104 40,377 -8,125 -16.75 1,685 -34.23 0.0124
2016-11-02 2016-09-30 13F AGIOS Pharmaceutical Common Stock 00847X104 48,502 -4,770 -8.95 2,562 14.78 0.0209
2016-07-27 2016-06-30 13F AGIOS Pharmaceutical Common Stock 00847X104 53,272 10,941 25.85 2,232 29.84 0.0198
2016-05-10 2016-03-31 13F Agios Pharmaceutical Common Stock 00847X104 42,331 -7,255 -14.63 1,719 -46.60 0.0177
2016-02-05 2015-12-31 13F Agios Pharmaceutical Common Stock 00847X104 49,586 49,586 3,219 0.0314
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.